Annals of Internal Medicine · 2008 · 504 citations · 34 references
MedicinePreventive MedicineUrologyCancer PreventionCancer ScreeningEarly DetectionFalse PositivesPreventive Care For MenProstate CancerProstate-specific Antigen TestingRisk-benefit AssessmentTargeted ScreeningFalse-negative Prostate-specific Antigen ResultsFalse-positive Prostate-specific Antigen ResultsFalse-positive ResultsProstate Cancer Detection Using Prostate-specific AntigenProstate Cancer DiagnosisProstate Cancer PreventionProstate ScreeningProstate-specific Antigen Screening False Positives
DESCRIPTION: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. METHODS: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. RECOMMENDATIONS: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).
34
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole, E. David Crawford, Robert L. Grubb et al. · New England Journal of Medicine · 2009 · 2.9K citations · Full text